Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 22, 2022
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
Sun, February 20, 2022
[ Sun, Feb 20th 2022
] - WOPRAI
[ Sun, Feb 20th 2022
] - WOPRAI
Fri, February 18, 2022
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
Michael King Maintained (AGIO) at Strong Buy with Increased Target to $98 on, Feb 18th, 2022
Michael King of HC Wainwright & Co., Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Increased Target from $95 to $98 on, Feb 18th, 2022.
Michael has made no other calls on AGIO in the last 4 months.
There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $42 on, Thursday, November 18th, 2021
These are the ratings of the 2 analyists that currently disagree with Michael
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $54 on, Friday, December 3rd, 2021
